The chronic mononucleosis syndrome

Journal of Infectious Diseases

Volumn 157, Issue 3, 1988, Pages 405-412

  Straus, Stephen E ^a,b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC DISEASE; EPSTEIN BARR VIRUS; FATIGUE; FEMALE; HUMAN; IMMUNOLOGY; MALE; MONONUCLEOSIS; MYASTHENIA; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; REVIEW; SEROLOGY;

CHRONIC DISEASE; FATIGUE; FEMALE; HERPESVIRIDAE; HERPESVIRUS 4, HUMAN; HUMAN; INFECTIOUS MONONUCLEOSIS; MALE; NEURASTHENIA; PSYCHOPHYSIOLOGIC DISORDERS; SYNDROME;

EID: 0023915874     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/157.3.405     Document Type: Article

References (45)

1. Jones JF, Ray CG, Minnich LL, Hicks MJ, Kibler R, Lucas DO. Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: Elevated anti-early antigen antibodies. Ann Intern Med 1985;102:1-7.
2. Straus SE, Tosato G, Armstrong G, Lawley T, Preble OT, Henle W, Davey R, Pearson G, Epstein J, Brus I, Blaese RM. Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med 1985; 102:7-16.
3. Barnes DM. Mystery disease at Lake Tahoe challenges virologists and clinicians. Science 1986;234:541-2.
4. Holmes GP, Kaplan JE, Stewart JA, Hunt B, Pinsky PF, Schonberger LB. A cluster of patients with a chronic mononucleosis-like syndrome. Is Epstein-Barr virus the cause? JAMA 1987;257:2297-302.
5. Miller G: Epstein-Barr virus. In: Fields BN, Knipe DM, Cha-nock RM, Melnick JL, Roizman B, Shope RE, eds. Virology. New York: Raven Press, 1985:563-89.
6. Sullivan JL, Woda BA, Herrod HG, Koh G, Rivara FP, Mulder C. Epstein-Barr virus-associated hemophagocytic syndrome: Virological and immunopathological studies. Blood 1985;65:1097-104.
7. Hanto DW, Frizzera G, Gajl-Peczalska KJ, Sakamoto K, Pur-tilo DT, Balfour HH Jr, Simmons RL, Najarian JS. Epstein-Barr virus-induced B-cell lymphoma after renal transplantation. Acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. New Engl J Med 1982;306:913-8.
8. Shearer WT, Ritz J, Finegold MJ, Guerra IC, Rosenblatt HM, Lewis DE, Pollack MS, Taber LH, Sumaya CV, Grumet FC, Cleary ML, Warnke R, Sklar J. Epstein-Barr virus-associated B-cell proliferations of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency. New Engl J Med 1985;312:1151-9.
9. Greenspan JS, Greenspan D, Lennette ET, Abrams DI, Conant MA, Peterson V, Freese UK. Replication of Epstein-Barr virus within the epithelial cells of oral “hairy” leukoplakia, an AIDS-associated lesion. New Engl J Med 1985;313: 1564-71.
10. Virelizier J-L, Lenoir G, Griscelli C. Persistent Epstein-Barr virus infection in a child with hypergammaglobulinaemia and immunoblastic proliferation associated with a selective defect in immune interferon secretion. Lancet 1978; 2:231-4.
11. Kuis W, Roord JJ, Zegers BJM, Rickinson AB, Kapsenberg JG, The H, Stoop JW. Heterogeneity of immune defects in three children with a chronic active Epstein-Barr virus infection. J Clin Immunol 1985;5:377-85.
12. Schooley RT, Carey RW, Miller G, Henle W, Eastman R, Mark EJ, Kenyon K, Wheeler EO, Rubin RH. Chronic Epstein-Barr virus infection associated with fever and interstitial pneumonitis. Clinical and serological features and response to antiviral chemotherapy. Ann Intern Med 1986;104: 636-43.
13. Miller G, Grogan E, Rowe D, Rooney C, Heston L, Eastman R, Andiman W, Niederman J, Henle W, Sullivan J, Schooley R, Vossen J, Strauss S, Issekutz T. Selective lack of antibody to a component of EB nuclear antigen in patients with chronic active Epstein-Barr virus infection. J Infect Dis 1987;156:26-35.
14. Henle W, Henle G, Andersson J, Ernberg I, Klein G, Hor-witz CA, Marklund G, Rymo L, Wellinder C, Straus SE. Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-l and EBNA-2 in acute and chronic Epstein-Barr virus infection. Proc Natl Acad Sci USA 1987;84:570-4.
15. Beard G. Neurasthenia, or nervous exhaustion. Boston Medical and Surgical Journal 1869;3 (new series):217-20.
16. Evans AC. Brucellosis in the United States. Am J Public Health 1947;37:139-51.
17. Zimmerman B, Weber E. Candida and “20th-century disease.” Can Med Assoc J 1985;133:965-6.
18. Yunus M, Masi AT, Calabro J J, Miller KA, Feigenbaum SL. Primary fibromyalgia (fibrositis): Clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 1981;11:151-71.
19. Truss CO. The role of Candida albicans in human illness. Journal of Orthomolecular Psychiatry 1981;10:165-75.
20. Sumaya CV. Endogenous reactivation of Epstein-Barr virus infections. J Infect Dis 1977;135:374-9.
21. Tobi M, Moraq A, Ravid Z, Chowers I, Feldman-Weiss V, Michaeli Y, Ben-Chetrit E, Shalit M, Knobler H. Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr virus infection. Lancet 1982;1:61-4.
22. Straus SE, Dale JK, Armstrong G, Preble O, Lawley T, Henle W. Acyclovir (ACV) treatment of a chronic fatigue syndrome with unusual EBV serologic profiles: Lack of efficacy in a controlled trial. Clin Res 1987;35:618A.
23. Horwitz CA, Henle W, Henle G, Rudnick H, Latts E. Longterm serological follow-up of patients for Epstein-Barr virus after recovery from infectious mononucleosis. J Infect Dis 1985;151:1150-3.
24. Gilliam AG. Epidemiologic study of an epidemic diagnosed as poliomyelitis, occurring among personnel of Los Angeles County General Hospital during the summer of 1934. Bulletin no. 240. Washington, DC: US Public Health Service, Division of Infectious Diseases, Institute of Health, 1938:1-90.
25. Acheson ED. The clinical syndrome variously called benign myalgic encephalomyelitis, Iceland disease and epidemic neuromyasthenia. Am J Med 1959;26:569-95.
26. Henderson DA, Shelokov A. Epidemic neuromyasthenia —clinical syndrome? N Engl J Med 1959;260:757-64, 814-8.
27. Medical Staff of the Royal Free Hospital. An outbreak of encephalomyelitis in the Royal Free Hospital Group, London, in 1955. Br Med J 1957;2:895-904.
28. McEvedy CP, Beard AW. Royal Free epidemic of 1955: A reconsideration. Br Med J 1970;1:7-11.
29. Cluff LE, Trever RW, Imboden JB, Canter A. Brucellosis. Medical aspects of delayed convalescence. AM A Archives of Internal Medicine 1959;103:398-405.
30. Imboden JB, Canter A, Cluff LE, Trever RW. Brucellosis. Psychologic aspects of delayed convalescence. AMA Archives of Internal Medicine 1959;103:406-14.
31. Imboden JB, Canter A, Cluff LE. Convalescence from influenza. A study of the psychological and clinical determinants. Arch Intern Med 1961;108:393-9.
32. Greenfield NS, Roessler R, Crosley AP Jr. Ego strength and length of recovery from infectious mononucleosis. J Nerv Ment Dis 1959;128:125-8.
33. Hamblin TJ, Hussain J, Akbar AN, Tang YC, Smith JL, Jones DB. Immunological reason for chronic ill health after infectious mononucleosis. Br Med J 1983;287:85-8.
34. Tosato G, Straus S, Henle W, Pike SE, Blaese RM. Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis). J Immunol 1985;134:3082-8.
35. Borysiewicz LK, Haworth SJ, Cohen J, Mundin J, Rickin-son A, Sissons JGP. Epstein-Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis. Q J Med 1986;58 (new series):lll-21.
36. Kibler R, Lucas DO, Hicks MJ, Poulos BT, Jones JF. Immune function in chronic active Epstein-Barr virus infection. J Clin Immunol 1985;5:46-54.
37. Caligiuri M, Murray C, Buchwald D, Levine H, Cheney P, Peterson D, Komaroff AL, Ritz J. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. J Immunol 1987;139:3306-13.
38. Schattner A, Wallach D, Merlin G, Hahn T, Levin S, Revel M. Assay of an interferon-induced enzyme in white blood cells as a diagnostic aid in viral diseases. Lancet 1981;2:497-500.
39. Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Stur-zenegger S, Kaplan M, Halligan G, Biberfeld P, Wong-Staal F, Kramarsky B, Gallo RC. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986;234:596-601.
40. Ablashi DV, Salahuddin SZ, Josephs SF, Imam F, Lusso P, Gallo RC, Hung C, Lemp J, Markham PD. HBLV (or HHV-6) in human cell lines [letter]. Nature 1987;329:207.
41. Salit IE. Sporadic postinfectious neuromyasthenia. Can Med Assoc J 1985;133:659-63.
42. Straus SE. EB or not EB —that is the question [editorial]. JAMA 1987;257:2335-6.
43. Scott GM. The toxic effects of interferon in man. In: Gresser I, Burke D, Cantell K, De Maeyer E, Landy M, Revel M, Vilcek J, eds. Interferon 1983. Vol 5. London: Academic Press, 1983:85-114.
44. Pert CB, Ruff MR, Weber RJ, Herkenham M. Neuropeptides and their receptors: A psychosomatic network. J Immunol 1985;135 (Suppl):820S-6S.
45. Stein M, Keller SE, Schleifer SJ. Stress and immunodula-tion: The role of depression and neuroendocrine function. J Immunol 1985;135 (Suppl):827S-33S.